"Single-Blind Method" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned.
| Descriptor ID |
D016037
|
| MeSH Number(s) |
E05.318.780.850 N05.715.360.780.730 N06.850.520.445.850
|
| Concept/Terms |
Single-Blind Method- Single-Blind Method
- Method, Single-Blind
- Methods, Single-Blind
- Single Blind Method
- Single-Blind Methods
- Single-Masked Method
- Method, Single-Masked
- Methods, Single-Masked
- Single Masked Method
- Single-Masked Methods
Single-Blind Study- Single-Blind Study
- Single Blind Study
- Single-Blind Studies
- Studies, Single-Blind
- Study, Single-Blind
Single-Masked Study- Single-Masked Study
- Single Masked Study
- Single-Masked Studies
- Studies, Single-Masked
- Study, Single-Masked
|
Below are MeSH descriptors whose meaning is more general than "Single-Blind Method".
Below are MeSH descriptors whose meaning is more specific than "Single-Blind Method".
This graph shows the total number of publications written about "Single-Blind Method" by people in this website by year, and whether "Single-Blind Method" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 5 | 5 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 4 | 4 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 5 | 5 |
| 2004 | 0 | 5 | 5 |
| 2005 | 0 | 6 | 6 |
| 2006 | 0 | 5 | 5 |
| 2007 | 0 | 5 | 5 |
| 2008 | 0 | 7 | 7 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 9 | 9 |
| 2011 | 0 | 5 | 5 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 13 | 13 |
| 2014 | 0 | 10 | 10 |
| 2015 | 0 | 8 | 8 |
| 2016 | 0 | 11 | 11 |
| 2017 | 0 | 11 | 11 |
| 2018 | 1 | 10 | 11 |
| 2019 | 0 | 8 | 8 |
| 2020 | 0 | 5 | 5 |
| 2021 | 0 | 6 | 6 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Single-Blind Method" by people in Profiles.
-
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial. JAMA. 2023 02 28; 329(8):651-661.
-
Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials. J ECT. 2022 09 01; 38(3):165-170.
-
Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B Cells. Arthritis Rheumatol. 2022 02; 74(2):200-211.
-
Early Convalescent Plasma for High-Risk Outpatients with Covid-19. N Engl J Med. 2021 11 18; 385(21):1951-1960.
-
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Br J Haematol. 2021 11; 195(4):612-620.
-
Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety: A Randomized Controlled Clinical Trial. Clin J Am Soc Nephrol. 2021 05 08; 16(5):776-784.
-
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021 04 10; 397(10282):1351-1362.
-
Computer-Assisted Measurement of Traumatic Brain Hemorrhage Volume Is More Predictive of Functional Outcome and Mortality than Standard ABC/2 Method: An Analysis of Computed Tomography Imaging Data from the Progesterone for Traumatic Brain Injury Experimental Clinical Treatment Phase-III Trial. J Neurotrauma. 2021 03; 38(5):604-615.
-
The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods. Int J Stroke. 2021 10; 16(7):873-880.
-
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.